z-logo
open-access-imgOpen Access
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Author(s) -
Anne Puel,
Sophie Cypowyj,
Jacinta Bustamante,
Jill F. Wright,
Luyan Liu,
Hye Kyung Lim,
Mélanie Migaud,
Laura Israël,
Maya Chrabieh,
Magali Audry,
Matthew Gumbleton,
A. Toulon,
Christine Bodemer,
Jamila El Baghdadi,
Matthew J. Whitters,
Theresa Paradis,
Jonathan Brooks,
Mary Collins,
Neil M. Wolfman,
Saleh AlMuhsen,
Miguel Galicchio,
Laurent Abel,
Capucine Pïcard,
JeanLaurent Casanova
Publication year - 2011
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.1200439
Subject(s) - chronic mucocutaneous candidiasis , candida albicans , immunology , mucocutaneous zone , cytokine , immunity , staphylococcus aureus , interleukin , biology , immune system , interleukin 17 , cytokine receptor , medicine , disease , microbiology and biotechnology , pathology , genetics , bacteria
Chronic mucocutaneous candidiasis disease (CMCD) is characterized by recurrent or persistent infections of the skin, nails, and oral and genital mucosae caused by Candida albicans and, to a lesser extent, Staphylococcus aureus, in patients with no other infectious or autoimmune manifestations. We report two genetic etiologies of CMCD: autosomal recessive deficiency in the cytokine receptor, interleukin-17 receptor A (IL-17RA), and autosomal dominant deficiency of the cytokine interleukin-17F (IL-17F). IL-17RA deficiency is complete, abolishing cellular responses to IL-17A and IL-17F homo- and heterodimers. By contrast, IL-17F deficiency is partial, with mutant IL-17F-containing homo- and heterodimers displaying impaired, but not abolished, activity. These experiments of nature indicate that human IL-17A and IL-17F are essential for mucocutaneous immunity against C. albicans, but otherwise largely redundant.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom